In recent years, cannabis has become increasingly prevalent in various settings such as pharmacies, parties, pain clinics, and political discussions. Many individuals utilize cannabis for purposes like improving sleep, relaxation, and pain management. Some even view it as a natural substitute for pharmaceuticals.
Yet, as society embraces cannabis, cardiovascular specialists have raised concerns. A groundbreaking study published in the journal Heart, which analyzed data from over 432 million individuals, has established a concerning correlation. The study indicates that users of cannabis face significantly heightened risks of heart attacks, strokes, and mortality from heart disease.
The growing accessibility of cannabis has stemmed from its legalized medicinal use in more than half of the U.S. states and certain European nations, including France, though recreational use remains prohibited in many regions. Despite legal restrictions, cannabis usage among young people in France remains prevalent, while Germany recently adopted changes to permit recreational use set for implementation in April 2024.
This increased cannabis consumption is accompanied by a rise in potency. Today’s cannabis products contain higher levels of THC, leading to more intense effects on both the brain and the cardiovascular system.
The researchers reviewed a total of 3,012 studies, of which 24 specifically examined the association between cannabis and severe heart-related issues. Their analysis reveals that cannabis users have a 29 percent greater likelihood of experiencing a heart attack, a 20 percent increased chance of having a stroke, and more than double the risk of dying from heart disease.
While stroke risk varies across different studies, occasional users tend to exhibit less pronounced dangers. However, regular usage, particularly among younger individuals, emerges as a cause for concern. One study conducted in Australia indicated that individuals who consumed cannabis weekly faced nearly a five-fold increase in the risk of stroke or mini-stroke. Moreover, data from a U.S. hospital database underscored a heightened risk primarily among those aged 25 to 34.
These findings suggest that while sporadic cannabis usage might not be significantly harmful, frequent consumption—especially among younger demographics—triggers increased risk factors.
Another alarming discovery from the research is the correlation between cannabis and heart attack incidence. One study determined that cannabis users aged 15 to 22 had a 36 percent increased likelihood of suffering a heart attack, with another study showing that those who used cannabis more than once a week exhibited more than double the risk of heart events.
This risk persists even after accounting for the influence of tobacco, cocaine, and other drugs, positioning cannabis as a strong predictor of heart problems, as evidenced by a study in France where cannabis proved to be a more significant risk factor than cocaine.
Such findings contradict the often optimistic narrative surrounding cannabis usage, illustrating that empirical data presents a more concerning picture.
The mortality risk from cardiovascular issues was also a focal point of analysis. Research indicated that younger patients experiencing heart attacks who also used cannabis demonstrated a markedly higher mortality rate. This correlation persisted even when accounting for variables such as smoking and pre-existing health conditions. A similar investigation in the United States revealed that cannabis users carry a significantly increased risk of dying from heart-related causes.
Interestingly, a 2024 study conducted in the UK highlighted a gender-based disparity, revealing that women rather than men faced elevated risks of heart-related fatalities due to heavy cannabis use.
While the risks associated with cannabis use are concerning, established medical benefits are recognized, especially under medical supervision. Cannabis has shown effectiveness in managing chronic pain for individuals grappling with conditions such as arthritis, multiple sclerosis, or nerve injuries.
The plant’s active compounds, particularly THC and CBD, engage with the body’s endocannabinoid system, resulting in diminished pain signaling and reduced inflammation. Medical cannabis is also administered to cancer patients to alleviate symptoms like nausea and vomiting related to chemotherapy, as well as to stimulate appetite in those facing weight loss during illness.
Moreover, cannabis has demonstrated potential in treating certain neurological disorders. In pediatric cases of epilepsy, CBD-based medications have been successful in reducing both the frequency and severity of seizures.
These examples showcase how the judicious use of cannabis can yield significant health benefits for patients—a factor that may overshadow concerns regarding its overall health implications.
Experts have called for tobacco-style warnings related to cannabis use. Professor Stanton Glantz and Dr. Lynn Silver argue that cannabis should be integrated into frameworks aimed at preventing cardiovascular diseases and that such diseases should be considered in the regulation of cannabis markets. They emphasize the need to recognize the potent nature of current cannabis strains, which encompass concentrates, synthetic variants, and an assortment of ingestible and inhalable forms—each potentially carrying unique risks.
The authors recommend treating cannabis similarly to tobacco, advocating for its discourage without criminalization while ensuring the safeguarding of bystanders from secondhand exposure. Medical professionals are urged to inquire about cannabis use during evaluations, particularly for patients who present with heart issues. For individuals who frequently consume cannabis, it may be time to reassess the perception of its harmlessness.
The findings from this pivotal study highlights a need for more informed discussions around cannabis consumption and cardiovascular health, as published in the journal Heart.
image source from：earth
